Inorgen’s participative vision: align research, patients, sponsors and professional community on the same goal.

Pharmaceuticals and Biotech

ACADEMIC CENTERS, R&D INSTITUTIONS

Source lead candidates to enable drug development.

case08

PATIENT ORGANIZATIONS and FOUNDATIONS

Identify specific needs and eventual assets that fit with an early stage development model.

scientist_ico

SCIENTISTS and CLINICIANS

Decisions to continue or stop the course of action. Enable a risk mitigation development program.

services5

DRUG DEVELOPMENT PROFESSIONALS

Accelerate the preparation of drug candidates partnering with experts in science, IP, regulatory, medical affairs, clinical research.

services7

VENTURE CAPITAL / CORPORATE VENTURE

Highlight development and regulatory requirements to attract capital into a new initiative. Operate with a milestone-driven, capital efficient approach.

New product development and launch

BIOPHARMA

Add opportunities to increase the pipeline in selected therapeutic areas achieving operational flexibility between internal and external resources.

 

Project requirements: premises for incubation.

MUST HAVE

∙ First or Best in Class

∙ Preclinical proof of concept

NICE TO HAVE

∙ Scientific publication

∙ Patent(s) and patentability study

Advisors and Professionals: liaising for project and company development.

Inorgen welcomes interactions with experienced individuals in the following areas:


Regulatory

Pharmacology/
Preclinical
Development

Translational
Medicine &
Medical Affairs

Business
Development/
Fundraising


IP & Legal

Inorgen